Cipher Pharmeuticals (CPH.TO)

Has some zip to it. Long term it should do well.

He likes this and has a fairly large position, but his average cost is $7. The challenge going forward as it goes higher, is that they have a very high dependence on a single product. The challenge over time is to get diversification into their portfolio. He thinks this can definitely go higher, but some of the smaller names such as Nobilis (NHC-T), Patient Home Monitoring (PHM-X) and CRH Medical (CRH-T) would be better. If you had $3000, you could spread it over these 3 as there is still a lot of growth, but he wouldn’t have exposure to one individual name.

He would recommend the 3 Top Picks for this show over this stock, because they are just getting going. All 3 of them are related to the Bio/medical/Pharma world.

This looks like it could be breaking out. Everything is going well with its products and its relationship with Dr. Reddy’s (RDY-N). Good management.